Summary
In this collaborative European study, a total of 4871 cystic fibrosis (CF) chromosomes and 3539 normal chromosomes have been characterized for the haplotypes defined by the 2 extragenic polymorphic sequences revealed by XV2c and KM19. The association between one of these haplotypes (B haplotype) and the most frequent CF mutation, ΔF508, suggests for the latter a single origin and a subsequent diffusion according to a South East-North West gradient. The linkage disequilibrium data between CF and the B haplotype in different European populations are compatible with a relatively more recent appearance of the mutation in Northern Europe whereas in Southern Europe a longer history of the same mutation would have allowed time for recombination with other haplotypes. This model is also compatible with a selective advantage of carriers but does not account for (1) the excess of B haplotypes observed among both normal and non-ΔF508 CF chromosomes; (2) the correlation between the B haplotype and the severity of the phenotypic effect caused by CF mutations, as measured by pancreatic insufficiency and meconium ileus.
Similar content being viewed by others
References
Ammerman AJ, Cavalli-Sforza LL (1984) The neolithic transition and the genetics of populations in Europe. Princeton University Press, Princeton
Attree O, Vidaud D, Vidaud M, Amselem S, Lavergne J, Goossens M (1989) Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior. Genomics 4:266–272
Ballabio A, Gibbs RA, Caskey CT (1990) PCR test for cystic fibrosis deletion. Nature 243:220
Beaudet AL, Spence JE, Montes M, O'Brien WE, Estivill X, Farrall M, Williamson R (1988) Experience with new DNA markers for the diagnosis of cystic fibrosis. N Engl J Med 318: 50–51
Beaudet AL, Feldman GL, Fernbach SD, Buffone GJ, O'Brien WE (1989) Linkage disequilibrium, cystic fibrosis and genetic counseling. Am J Hum Genet 44:319–326
Boat TF, Welsh MJ, Beaudet AL (1989) Cystic fibrosis. In: Scriver CL, Beaudet AL, Sly S, Valle D (eds) Metabolic basis of inherited disease. McGraw-Hill, New York, pp 2649–2680
Corey M, Durie P, Moore D, Forstner G, Levison H (1989) Familial concordance of pancreatic function in cystic fibrosis. J Pediatr 115: 274–177
Coutelle C, Briickner R, Speer A, Grade K, Huth A, Szibor R, Gedschold J, Bittorf T, Brock J, Hein J, Brell U, Williamson R (1989) DNA-analysis in cystic fibrosis families from the German Democratic Republic (abstract). (10th International Workshop on Human Gene Mapping) Cytogenet Cell Genet 51:979–980
Curtis A, Jackson J, Keston M, Brock DJH (1989) Genetic differences between cystic fibrosis with and without meconium ileus. Lancet 1:1058–1059
Cutting GR, Antonarakis SE, Buetow KH, Kasch LM, Rosenstein BJ, Kazazian HH (1989) Analysis of DNA polymorphism haplotypes linked to the cystic fibrosis locus in North American black and Caucasian families supports the existence of multiple mutation of the cystic fibrosis gene. Am J Hum Genet 44:307–318
De Benedetti L, Ronchetto P, Devoto M, Romeo G, Krainiaia GV, Reznik BY (1989) Preliminary results on CF haplotypes from patients diagnosed in Odessa (USSR). 16th Annual Meeting of the European Working Group for Cystic Fibrosis, Prague 1989, p 159
Devoto M, De Benedetti L, Seia M, Piceni Sereni L, Ferrari M, Bonduelle ML, Malfroot A, Lissens W, Balassopoulou A, Adam G, Loukopoulos D, Cochaux P, Vassart G, Szibor R, Hein J, Grade K, Berger W, Wainwright B, Romeo G (1989) Haplotypes in cystic fibrosis patients with or without pancreatic insufficiency from four European populations. Genomics 5: 894–898
Estivill X, Farrall M, Scambler PJ, Bell G, Hawley KMF, Lench NJ, Bates P, Kruyer HC, Frederick PA, Stainer P, Watson EK, Williamson R, Wainwright BJ (1987a) A candidate for the cystic fibrosis locus isolated by selection for the methylationfree islands. Nature 326:840–845
Estivill X, Scambler PJ, Wainwright BJ, Hawley K, Frederick P, Baiget M, Kere J, Williamson R, Farrall M (1987b) Patterns of polymorphism and linkage disequilibrium for cystic fibrosis. Genomics 1:257–263
Estivill X, Farrall M, Williamson R, Ferrari M, Seia M, Giunta A, Novelli G, Potenza L, Dallapiccola B, Borgo G, Gasparini P, Pignatti PIT, De Benedetti L, Vitale E, Devoto M, Romeo G (1988) Linkage disequilibrium between cystic fibrosis and linked DNA markers in Italian families: a collaborative study. Am J Hum Genet 43:23–28
Estivill X, Chillon M, Casals T, Bosch A, Morral N, Nunes V, Gasparini P, Seia A, Pignatti PF, Novelli G, Dallapiccola B, Fernandez E, Benitez J, Williamson R (1989a) ΔF508 gene deletion in cystic fibrosis in Southern Europe. Lancet II:1404–1405
Estivill X, McLean C, Nunes V, Casals T, Gallano P, Scambler PJ, Williamson R (1989b) Isolation of a new DNA marker in linkage disequilibrium with cystic fibrosis situated between J3.11 (D7S8) and IRP. Am J Hum Genet 44:704–710
Estivill X, Gasparini P, Novelli G, Casals T, Nunes V, Gallano P, Savoia A, Ruzzo A, Dallapiccola B, Pignatti PF (1989c) Linkage disequilibrium for DNA haplotypes near the cystic fibrosis locus in two South European populations. Hum Genet 83:175–178
Feldman GL, Williamson R, Beaudet AL, O'Brien WE (1988) Prenatal diagnosis of cystic fibrosis by DNA amplification for detection of KM-19 polymorphism. Lancet 11:102
Ferrari M, Antonelli M, Bellini F, Borgo G, Castiglione O, Curcio L, Dallapiccola B, Devoto M, Estivill X, Gasparini P, Giunta A, Marianelli L, Mastella G, Novelli G, Pignatti PIT, Romano L, Romeo G, Seia M, Williamson R (1990) Genetic differences in cystic fibrosis patients with and without pancreatic insufficiency. An Italian collaborative study. Hum Genet 84:435–438
Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, Forstner G (1982) Improved respiratory prognosis in patients with cystic fibrosis with normal fat absorption. J Pediatr 100:857–862
Gasparini P, Cappello N, Dallapiccola B, Devoto M, Estivill X, Ferrari M, Leoni G, Novelli G, Piazza A, Pignatti PF, Rosatelli C, Romeo G, Savoia A, Seia M, Williamson R (1990a) Regional distribution of cystic fibrosis linked DNA haplotypes in Italy, a collaborative study. Gene Geography 4:53–64
Gasparini P, Novelli G, Estivill X, Olivieri D, Savoia A, Ruzzo A, Nunes V, Borgo G, Antonelli M, Williamson R, Pignatti PF, Dallapiccola B (1990b) The genotype of a new linked DNA marker, MP6d-9, is related to the clinical course of cystic fibrosis. J Med Genet 27:17–20
Halley DJ, Damme NHM van, Deelen WH, et al (1989) Prenatal detection of major cystic fibrosis mutation. Lancet II:972
Harris A (1990) DNA markers near the cystic fibrosis locus: further analysis of the British population. J Med Genet 27:39–41
Harris A, Quinlan C, Bobrow M (1988) Cystic fibrosis typing with DNA probes: experience of a screening laboratory. Hum Genet 79:76–79
Health Statistics (1987) Department of Health, The Stationery Office, Planning Unit, Dublin, Ireland
Hill AJM, Graham CA, Kelly ED, Morrison PJ, Nevin NC (1989) Linkage disequilibrium and CF allele segregation analysis in cystic fibrosis families in Northern Ireland. Hum Genet 83:391–394
Hill WG, Robertson A (1968) Linkage disequilibrium in finite populations. Theor Appl Genet 38:226–231
Holloway S, Brock DJH (1989) Risks of fetal cystic fibrosis based on linkage disequilibrium data. Hum Genet 83:52–54
Huth A, Estivill X, Grade K, Billwitz H, Speer A, Rosenthal A, Williamson R, Ramsay M, Coutelle C (1989) Polymerase chain reaction for detection of the pMP6d.9/MspI RFLP, a marker closely linked to the cystic fibrosis mutation. Nucleic Acids Res 17:7118
Isolauri J, Uitti J, Visakorpi JK (1979) Screening of cystic fibrosis in newborn (in Finnish). Duodecim 95:16–19
Ivinson AJ, Read AP, Harris R, Super M, Schwarz M, Clayton Smith J, Elles R (1989) Testing for cystic fibrosis using allelic association. J Med Genet 26:426–430
Jorde LB, Lathrop GM (1988) A test of the heterozygote-advantage hypothesis in cystic fibrosis carriers. Am J Hum Genet 42:808–815
Kalaydjieva L, Eigel A, Horst J (1989) The molecular basis of beta-thalassemia in Bulgaria. J Med Genet 26:614–618
Kalaydjieva L, Plageras P, Horst J (1990) Further evidence of CF heterogeneity in Southern Europe. Hum Hered (in press)
Kazazian HH Jr, Orkin SH, Markham AF, Chapman CR, Youssoufian H, Waber PG (1984) Quantification of the close association between DNA haplotpyes and specific β-thalassemia mutations in Mediterraneans. Nature 310:152–154
Kere J, Norio R, Savilahti E, Estivill X, Chapelle A de la (1989) Cystic fibrosis in Finland: a molecular and genealogical study. Hum Genet 83:20–25
Kerem BS, Buchanan JA, Durie P, Corey ML, et al (1989a) DNA marker haplotype association with pancreatic sufficiency in cystic fibrosis. Am J Hum Genet 44:827–834
Kerem BS, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui LC (1989b) Identification of the cystic fibrosis gene: genetic analysis. Science 245:1073–1080
Kitzis A, et al (1988) Unusual segregation of cystic fibrosis alleles. Nature 336:316
Krawczak M, Konecki DS, Schmidtke J, Dück M, Engel W, Nützenadel W, Trefz FK (1988) Allelic association of the cystic fibrosis locus and two DNA markers, XV2c and KM19, in 55 German families. Hum Genet 80:78–80
Lemna WK, Feldman GL, Kerem BS, Fernbach SD, Zevcovich EP, O'Brien WE, Riordan JR, Collins FS, Tsui LP, Beaudet AL (1990) Mutation analysis for heterozygote detection and the prenatal diagnosis of cystic fibrosis. N Engl J Med 322:291–296
Lerman L, Silverstein K (1987) Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 155:482–501
Lichter-Konecki U, Schlotter M, Yaylak C, Özgiic M, Coskun T, Özalp I, Wendel U, Batzler U, Trefz FK, Konecki D (1989) DNA haplotype analysis at the phenylalanine hydroxylase locus in the Turkish population. Hum Genet 81:373–376
Maciejko D, Bal J, Mazurczak T, Te Meerman G, Buys C, Oostra B, Halley D (1989) Different haplotypes for cystic fibrosislinked DNA polymorphisms in Polish and Dutch populations. Hum Genet 83:220–222
Mathew CG, Roberts RG, Harris A, Bentley DR, Bobrow M (1989) Rapid screening for ΔF508 deletion in cystic fibrosis. Lancet II:1346
McGourty C (1989) CF screening premature? Nature 342:334
McIntosh I, Lorenzo ML, Brock DJH (1989a) Frequency of the delta F508 mutation on cystic fibrosis chromosomes in UK. Lancet II: 1404–1405
McIntosh I, Raeburn JA, Curtis A, Brock DJH (1989b) Firsttrimester prenatal diagnosis of cystic fibrosis by direct gene probing. Lancet II:972–973
Meindl RS (1987) Hypothesis: a selective advantage for cystic fibrosis heterozygotes. Am J Phys Anthropol 74:39–45
Menozzi P, Piazza A, Cavalli-Sforza LL (1978) Synthetic maps of human gene frequencies in Europeans. Science 201:786–792
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1214
Mornet E, Simon-Bouy B, Serre JL, Estivill X, Farrall M, Williamson R, Boué J, Boué A (1988) Genetic differences between cystic fibrosis with and without meconium ileus. Lancet I:376–378
Mornet E, Simon-Bouy B, Serre JL, Muller F, Taillandier A, Fernandez M, Boué J, Boué A (1989) Genetic heterogeneity between two clinical forms of cystic fibrosis evidenced by familial analysis and linked DNA probes. Clin Genet 35:81–87
Myers R, Maniatis T, Lerman L (1987) Detection and localization of single base changes by denaturing gradient gel electrophoresis. Methods Enzymol 155:501–527
Newton CR, Graham A, Heptinstall LE, et al (1989) Analysis of any point mutation in DNA. The amplification refractory mutation system. Nucleic Acids Res 17:2503–2516
Nielsen OH, Thomsen BL, Green A, Andersen PK, Hauge M, Schiøtz PO (1988) Cystic fibrosis in Denmark 1945 to 1985. An analysis o£ incidence, mortality and influence of centralized treatment on survival. Acta Paediatr Scand 77:836–841
Northrup H, Rosenbloom C, O'Brien WE, Beaudet AL (1989) Additional polymorphism for D7S8 linked to cystic fibrosis including detection by DNA amplification. Nucleic Acids Res 17:1784
Nunes V, Casals T, Gallano P, Gimenez FJ, Kere J, Williamson R, Estivill X (1989) Detection of a rare allele with pMP6d-9/MspI RFLP near the cystic fibrosis locus. Hum Genet 83:305–306
Piazza A, Menozzi P, Cavalli-Sforza LL (1981) The making and testing of geographic gene-frequency maps. Biometrics 37:635–659
Piazza A, Cappello N, Olivetti E, Rendine S (1988) A genetic history of Italy. Ann Hum Genet 52:203–213
Ramsay M, Williamson R, Wainwright BJ, Estivill X, Farrall M, Ho MF, Halford S, Kere Y, Savilahti E, Chapelle A de la, Schwartz M, Schwartz M, Super M, Farndon P, Harding C, Meredith L, Al-Jader L, Ferec C, Claustres M, Casals T, Nunes V, Gasparini P, Savoia A, Pignatti PF, Novelli G, Gennarelli M, Dallapiccola B, Kalaydjieva L, Scambler PJ (1990a) Haplotype analysis to determine the position of a mutation among closely linked DNA markers: cystic fibrosis. (Submitted for publication)
Ramsay M, Wainwright BJ, Farrall M, Estivill X, Sutherland H, Ho M-F, Davies R, Halford S, Tata F, Wicking C, Lench N, Bauer I, Ferec C, Farndon P, Kruyer H, Stanier P, Williamson R, Scambler PJ (1990b) A new polymorphic locus D7S411, isolated by cloning from preparative pulse field gels is close to the mutation causing cystic fibrosis. Genomics 6:39–47
Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, Iannuzzi MC, Collins FS, Tsui L-C (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245:1066–1073
Romeo G, Galietta JLV, Devoto M (1989) Why is the CF gene so frequent? Am Hum Genet 84:1–5
Rommens J, Iannuzzi MC, Kerem BS, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui L-C, Collins FS (1989) Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 245:1059–1065
Rommens J, Kerem BS, Greer W, Chang P, Tsui L-C, Ray P (1990) Rapid nonradioactive detection of the major CF mutation. Am J Hum Genet 46:395–396
Rosenbloom CL, Kerem BS, Rommens JM, Tsui L-C, Wainwright B, Williamson R, O'Brien WE, Beaudet AL (1989) DNA amplification for detection of the XV-2c polymorphism linked to cystic fibrosis. Nucleic Acids Res 17:7117
Scheffer H, Verlind E, Penninga D, Te Meerman G, Ten Kate L, Buys C (1989) Rapid screening for ΔF508 deletion in cystic fibrosis. Lancet II:1345–1346
Schwarz MJ, Summers C, Heptinstall LE, Newton C, Markham A, Super M (1990) A new deletion mutation of the cystic fibrosis transmembrane conductance regulator (CFTR) locus: delta 1507. In: Tsui LC, Romeo G, Greger R, Gorini S (1990) The identification of the CF gene: recent progress and new research strategies. Raven Press, New York (in press)
Serre JL, Simon-Bouy B, Mornet E, Jaume-Roig B, Balassopoulou A, Schwartz M, Taillandier A, Boué J, Boué A (1990) Studies of RFLP closely linked to the cystic fibrosis locus throughout Europe lead to new considerations in population genetics. Hum Genet 84:449–454
Sheffield V, Cox D, Lerman L (1989) Attachment of a 40-basepair G+C-rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single-base changes. Proc Natl Acad Sci USA 86:232–236
Speer A, Neumann R, Bollmann R, Bommer C, Hanke R, Hunger H-D, Szibor R, Flachmeier C, Grade K, Peter H, Gedschold J, Weise W, Bittorf T, Brock J, Hein J, Graupner J, Coutelle C (1987) Erste Erfahrungen mit der genomischen pränatalen Diagnostik der cystischen Fibrose in der DDR. Z Klin Med 42:2257–2260
Speer A, Grade K, Hanke R, Brell U, Szibor R, Bollmann R, Neumann R, Coutelle C (1990) Die Einführung der Genamplifikationstechnik in die genomische Diagnostik der zystischen Fibrose in der DDR. Z Klin Med (in press)
Strain L, Curtis A, Mennie M, Holloway S, Brock DJH (1988) Use of linkage disequilibrium data in prenatal diagnosis of cystic fibrosis. Hum Genet 80:75–77
Stuhrmann M, Riess O, Mönch E, Kurdoglu G (1989) Haplotype analysis of the phenylalanine hydroxylase gene in Turkish phenylketonuria families. Clin Genet 36:117–121
Super M (1978) Cystic fibrosis in South West Africa. MD thesis, University of Cape Town
Ten Kate LP (1977) Cystic fibrosis in the Netherlands. Int J Epidemiol 6:23–34
Ten Kate LP, Tijmstra TJ (1989) Carrier screening for cystic fibrosis. Lancet II:973–974
Tümmler B, Aschendorff A, Darnedde T, Fryburg K, Maass G, Hundrieser J (1990) Marker haplotype association with growth in German cystic fibrosis patients. Hum Genet 84:267–273
Vidaud M, Kitzis A, Ferec C, Bozon D, Dumur V, Giraud G, David F, Pascal O, Auvinet M, Morel Y, Andre J, Chomel J, Saleun J, Farriaux J, Roussel P, Labbe A, Dastugue B, Lucotte G, Monnier M, Goossens M, Feingold J, Kaplan J (1989) Confirmation of linkage disequilibrium between haplotype B (XV-2c: allele 1; KM-19: allele 2) and cystic fibrosis gene in French population. Hum Genet 81:183–184
Vogel F, Motulsky AG (1979) Human genetics — problems and approaches. Springer, Berlin Heidelberg New York
Wagener DK, Cavalli-Sforza LL (1975) Ethnic variation and genetic disease: possible roles of hitch-hiking and epistasis. Am J Hum Genet 27:348–364
Wagner M, Schloesser M, Reiss J (1990) Direct gene diagnosis of cystic fibrosis by allele specific polymerase chain reaction. Mol Biol Med (in press)
Wainscoat JS (1987) The origin of mutant β-globin genes in human populations. Acta Haematol (Basel) 78:154–158
Williams C, Williamson R, Coutelle C, Loeffler F, Smith J, Ivinson A (1988) Same-day, first-trimester antenatal diagnosis for cystic fibrosis by gene amplification. Lancet II:102–103
Wright SW, Morton NE (1968) Genetic studies on cystic fibrosis in Hawaii. Am J Hum Genet 20:157–169
Author information
Consortia
Rights and permissions
About this article
Cite this article
European Working Group on CF Genetics (EWGCFG). Gradient of distribution in Europe of the major CF mutation and of its associated haplotype. Hum Genet 85, 436–445 (1990). https://doi.org/10.1007/BF02428304
Issue Date:
DOI: https://doi.org/10.1007/BF02428304